|
|
The present Competitive Intelligence Report about anti-CD30 antibody-based constructs used to treat lymphomas provides a competitor evaluation in the field of R&D projects with anti-CD30 antibodies as of January 2009. The report includes a compilation of current active projects in research and development of anti-CD22 antibodies. Competitor projects are listed in a tabular format providing information on:
|
Additional Information
Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced. Competitor analysis reports can be purchased as individual products or obtained by subscribing to R&D Pipeline News. R&D Pipeline News is published weekly 50-times a year and each issue contains at least two competitor evaluations.
